{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:05:20Z","timestamp":1784311520394,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PROFAPI","award":["2015\/182"],"award-info":[{"award-number":["2015\/182"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerged coronavirus responsible for coronavirus disease 2019 (COVID-19); it become a pandemic since March 2020. To date, there have been described three lineages of SARS-CoV-2 circulating worldwide, two of them are found among Mexican population, within these, we observed three mutations of spike (S) protein located at amino acids H49Y, D614G, and T573I. To understand if these mutations could affect the structural behavior of S protein of SARS-CoV-2, as well as the binding with S protein inhibitors (cepharanthine, nelfinavir, and hydroxychloroquine), molecular dynamic simulations and molecular docking were employed. It was found that these punctual mutations affect considerably the structural behavior of the S protein compared to wild type, which also affect the binding of its inhibitors into their respective binding site. Thus, further experimental studies are needed to explore if these affectations have an impact on drug-S protein binding and its possible clinical effect.<\/jats:p>","DOI":"10.1038\/s41598-021-84053-8","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T11:04:11Z","timestamp":1614251051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population"],"prefix":"10.1038","volume":"11","author":[{"given":"Yudibeth","family":"Sixto-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Correa-Basurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martiniano","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Landeros-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Garz\u00f3n-Tiznado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"84053_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nsmb1123","volume":"13","author":"DR Beniac","year":"2006","unstructured":"Beniac, D. R., Andonov, A., Grudeski, E. & Booth, T. F. Architecture of the SARS coronavirus prefusion spike. Nat. Struct. Mol. Biol. 13, 751\u2013752 (2006).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"84053_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292 (2020).","journal-title":"Cell"},{"key":"84053_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0184-0","author":"S Xia","year":"2020","unstructured":"Xia, S. et al. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Signal Transduct. Target. Ther. https:\/\/doi.org\/10.1038\/s41392-020-0184-0 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"84053_CR4","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1128\/JVI.02615-14","volume":"89","author":"F Li","year":"2015","unstructured":"Li, F. Receptor recognition mechanisms of coronaviruses: A decade of structural studies. J. Virol. 89, 1954\u20131964 (2015).","journal-title":"J. Virol."},{"key":"84053_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Lett. Nat. 426, 450\u2013454 (2003).","journal-title":"Lett. Nat."},{"key":"84053_CR6","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard, B. et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176, 104742 (2020).","journal-title":"Antiviral Res."},{"key":"84053_CR7","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","volume":"117","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. U.S.A. 117, 11727 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"84053_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.15.151779","author":"S Ozono","year":"2020","unstructured":"Ozono, S. et al. Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry. BioRxiv. https:\/\/doi.org\/10.1101\/2020.06.15.151779 (2020).","journal-title":"BioRxiv."},{"key":"84053_CR9","doi-asserted-by":"publisher","first-page":"104389","DOI":"10.1016\/j.meegid.2020.104389","volume":"84","author":"S Mohammad","year":"2020","unstructured":"Mohammad, S. et al. Infection, genetics and evolution exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach. Infect. Genet. Evol. 84, 104389 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"84053_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01056-20","author":"B Taboada","year":"2020","unstructured":"Taboada, B. et al. Genomic analysis of early SARS-CoV-2 variants introduced in Mexico. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01056-20 (2020).","journal-title":"J. Virol."},{"key":"84053_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13525","author":"M Becerra-Flores","year":"2020","unstructured":"Becerra-Flores, M. & Cardozo, T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int. J. Clin. Pract. https:\/\/doi.org\/10.1111\/ijcp.13525 (2020).","journal-title":"Int. J. Clin. Pract."},{"key":"84053_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.12.148726","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. BioRxiv. https:\/\/doi.org\/10.1101\/2020.06.12.148726 (2020).","journal-title":"BioRxiv."},{"key":"84053_CR13","doi-asserted-by":"publisher","first-page":"104445","DOI":"10.1016\/j.meegid.2020.104445","volume":"85","author":"S Laha","year":"2020","unstructured":"Laha, S. et al. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infect. Genet. Evol. 85, 104445 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"84053_CR14","first-page":"45","volume":"53","author":"P Ing","year":"2013","unstructured":"Ing, P., Bello, I., Areiza, M. & Oliver, J. \u6e08\u7121 no title no title. J. Chem. Inf. Model. 53, 45\u201350 (2013).","journal-title":"J. Chem. Inf. Model."},{"key":"84053_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s43440-020-00132-z","volume":"72","author":"M Rogosnitzky","year":"2020","unstructured":"Rogosnitzky, M., Okediji, P. & Koman, I. Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacol. Rep. 72, 1509\u20131516 (2020).","journal-title":"Pharmacol. Rep."},{"key":"84053_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00819-20","author":"S Jeon","year":"2020","unstructured":"Jeon, S. et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00819-20 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"84053_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","volume":"133","author":"H-H Fan","year":"2020","unstructured":"Fan, H.-H. et al. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin. Med. J. (Engl.) 133, 1051\u20131056 (2020).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"84053_CR18","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li, F., Li, W., Farzan, M. & Harrison, S. C. Structural biology: Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309, 1864\u20131868 (2005).","journal-title":"Science"},{"key":"84053_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"84053_CR20","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11871402.v3","author":"M Smith","year":"2020","unstructured":"Smith, M. & Smith, J. Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv.11871402.v3 (2020).","journal-title":"ChemRxiv."},{"key":"84053_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cmi.2020.05.016","volume":"26","author":"C Rodrigo","year":"2020","unstructured":"Rodrigo, C., Fernando, S. D. & Rajapakse, S. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: A systematic review. Clin. Microbiol. Infect. 26, 979\u2013987 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"84053_CR22","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1021\/jm0601856","volume":"49","author":"C Biot","year":"2006","unstructured":"Biot, C. et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J. Med. Chem. 49, 2845\u20132849 (2006).","journal-title":"J. Med. Chem."},{"key":"84053_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40495-020-00231-8","volume":"6","author":"S Satarker","year":"2020","unstructured":"Satarker, S. et al. Hydroxychloroquine in COVID-19: Potential mechanism of action against SARS-CoV-2. Curr. Pharmacol. Rep. 6, 203\u2013211 (2020).","journal-title":"Curr. Pharmacol. Rep."},{"key":"84053_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"X Yao","year":"2020","unstructured":"Yao, X. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis. 71, 732\u2013739 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"84053_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 6, 16 (2020).","journal-title":"Cell Discov."},{"key":"84053_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-020-12200-1","author":"R Kumar","year":"2021","unstructured":"Kumar, R. et al. Hydroxychloroquine in COVID-19: Therapeutic promises, current status, and environmental implications. Environ. Sci. Pollut. Res. https:\/\/doi.org\/10.1007\/s11356-020-12200-1 (2021).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"84053_CR27","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti, A. B. et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19. N. Engl. J. Med. 383, 2041\u20132052 (2020).","journal-title":"N. Engl. J. Med."},{"key":"84053_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1782265","author":"M Nimgampalle","year":"2020","unstructured":"Nimgampalle, M., Devanathan, V. & Saxena, A. Screening of Chloroquine, hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1782265 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"84053_CR29","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1796811","author":"P Pandey","year":"2020","unstructured":"Pandey, P. et al. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1796811 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"84053_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.antiviral.2010.06.010","volume":"88","author":"L-E Hsieh","year":"2010","unstructured":"Hsieh, L.-E. et al. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antiviral Res. 88, 25\u201330 (2010).","journal-title":"Antiviral Res."},{"key":"84053_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbrc.2004.04.083","volume":"318","author":"N Yamamoto","year":"2004","unstructured":"Yamamoto, N. et al. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem. Biophys. Res. Commun. 318, 719\u2013725 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"84053_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25985","author":"F Musarrat","year":"2020","unstructured":"Musarrat, F. et al. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.25985 (2020).","journal-title":"J. Med. Virol."},{"key":"84053_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.03.186825","author":"M Sikora","year":"2020","unstructured":"Sikora, M. et al. Map of SARS-CoV-2 spike epitopes not shielded by glycans. BioRxiv. https:\/\/doi.org\/10.1101\/2020.07.03.186825 (2020).","journal-title":"BioRxiv."},{"key":"84053_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/bip.22130","volume":"99","author":"L Tolentino-Lopez","year":"2013","unstructured":"Tolentino-Lopez, L. et al. Outside-binding site mutations modify the active site\u2019s shapes in neuraminidase from influenza A H1N1. Biopolymers 99, 10\u201321 (2013).","journal-title":"Biopolymers"},{"key":"84053_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.043","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.06.043 (2020).","journal-title":"Cell"},{"key":"84053_CR36","unstructured":"Eaaswarkhanth, M., Madhoun, A. A. & Al-mulla, F. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID-19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company\u2019s Public NEWS and information (2020)."},{"key":"84053_CR37","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/jcm9051473","volume":"9","author":"U Kalathiya","year":"2020","unstructured":"Kalathiya, U. et al. Highly conserved homotrimer cavity formed by the SARS-CoV-2 spike glycoprotein: A novel binding site. J. Clin. Med. 9, 1473 (2020).","journal-title":"J. Clin. Med."},{"key":"84053_CR38","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11877492.v2","author":"C Peng","year":"2020","unstructured":"Peng, C. et al. Computational study of the strong binding mechanism of SARS-CoV-2 spike and ACE2. ChemRxiv. https:\/\/doi.org\/10.26434\/chemrxiv.11877492.v2 (2020).","journal-title":"ChemRxiv."},{"key":"84053_CR39","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/jcc.26383","volume":"41","author":"IO Omotuyi","year":"2020","unstructured":"Omotuyi, I. O. et al. Atomistic simulation reveals structural mechanisms underlying D614G spike glycoprotein-enhanced fitness in SARS-COV-2. J. Comput. Chem. 41, 2158\u20132161 (2020).","journal-title":"J. Comput. Chem."},{"key":"84053_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.29.069054","author":"B Korber","year":"2020","unstructured":"Korber, B. et al. Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. BioRxiv. https:\/\/doi.org\/10.1101\/2020.04.29.069054 (2020).","journal-title":"BioRxiv."},{"key":"84053_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.14.039925","author":"H Ohashi","year":"2020","unstructured":"Ohashi, H. et al. Multidrug treatment with nelfinavir and cepharanthine against COVID-19. ChemRxiv. https:\/\/doi.org\/10.1101\/2020.04.14.039925 (2020).","journal-title":"ChemRxiv."},{"key":"84053_CR42","first-page":"410","volume":"19","author":"JT Ortega","year":"2020","unstructured":"Ortega, J. T., Serrano, M. L., Pujol, F. H. & Rangel, H. R. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 19, 410\u2013417 (2020).","journal-title":"EXCLI J."},{"key":"84053_CR43","doi-asserted-by":"publisher","first-page":"106020","DOI":"10.1016\/j.ijantimicag.2020.106020","volume":"56","author":"J Fantini","year":"2020","unstructured":"Fantini, J., Chahinian, H. & Yahi, N. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. Int. J. Antimicrob. Agents 56, 106020 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"84053_CR44","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1021\/ja100936w","volume":"132","author":"ER Johnson","year":"2010","unstructured":"Johnson, E. R. et al. Revealing noncovalent interactions. J. Am. Chem. Soc. 132, 6498\u20136506 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"84053_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1021\/acs.jctc.5b00330","volume":"12","author":"J Gonz\u00e1lez","year":"2016","unstructured":"Gonz\u00e1lez, J. et al. Unravelling protein\u2013DNA interactions at molecular level: A DFT and NCI study. J. Chem. Theory Comput. 12, 523\u2013534 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"84053_CR46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.str.2018.04.006","volume":"26","author":"R Raucci","year":"2018","unstructured":"Raucci, R., Laine, E. & Carbone, A. Local interaction signal analysis predicts protein-protein binding affinity. Structure 26, 905\u2013915 (2018).","journal-title":"Structure"},{"key":"84053_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.comptc.2013.11.020","volume":"1028","author":"C Barberot","year":"2014","unstructured":"Barberot, C. et al. AlgoGen: A tool coupling a linear-scaling quantum method with a genetic algorithm for exploring non-covalent interactions. Comput. Theor. Chem. 1028, 7\u201318 (2014).","journal-title":"Comput. Theor. Chem."},{"key":"84053_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/430_2015_197","volume-title":"The Chemical Bond II","author":"PLA Popelier","year":"2016","unstructured":"Popelier, P. L. A. Quantum chemical topology. In The Chemical Bond II (eds Michael, D. & Mingos, P.) 71\u2013117 (Springer, Cham, 2016)."},{"key":"84053_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/wcms.1497","author":"R Laplaza","year":"2020","unstructured":"Laplaza, R. et al. NCIPLOT and the analysis of noncovalent interactions using the reduced density gradient. WIREs Comput. Mol. Sci. https:\/\/doi.org\/10.1002\/wcms.1497 (2020).","journal-title":"WIREs Comput. Mol. Sci."},{"key":"84053_CR50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1021\/acs.jcim.9b00950","volume":"60","author":"F Peccati","year":"2020","unstructured":"Peccati, F. NCIPLOT4 guide for biomolecules: An analysis tool for noncovalent interactions. J. Chem. Inf. Model. 60, 6\u201310 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"84053_CR51","first-page":"1","volume-title":"Design of Organic Solids","author":"JP Glusker","year":"1998","unstructured":"Glusker, J. P. Directional aspects of intermolecular interactions. In Design of Organic Solids (eds Weber, E. et al.) 1\u201356 (Springer, Berlin, 1998)."},{"key":"84053_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10587259208025806","volume":"211","author":"GR Desiraju","year":"1992","unstructured":"Desiraju, G. R. DESIRAJU: C-H \u2026 0 hydrogen bonding and the deliberate design of organic crystal structures. Mol. Cryst. Liq. Cryst. Sci. Technol. Sect. A Mol. Cryst. Liq. Cryst. 211, 63\u201374 (1992).","journal-title":"Mol. Cryst. Liq. Cryst. Sci. Technol. Sect. A Mol. Cryst. Liq. Cryst."},{"key":"84053_CR53","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1002\/chem.200204626","volume":"9","author":"CF Matta","year":"2003","unstructured":"Matta, C. F., Hern\u00e1ndez-Trujillo, J., Tang, T.-H. & Bader, R. F. W. Hydrogen\u2013hydrogen bonding: A stabilizing interaction in molecules and crystals. Chem. A Eur. J. 9, 1940\u20131951 (2003).","journal-title":"Chem. A Eur. J."},{"key":"84053_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","volume":"22","author":"Y Shu","year":"2017","unstructured":"Shu, Y. & McCauley, J. GISAID: Global initiative on sharing all influenza data\u2014From vision to reality. Eurosurveillance 22, 2\u20134 (2017).","journal-title":"Eurosurveillance"},{"key":"84053_CR55","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview version 2\u2014A multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189\u20131191 (2009).","journal-title":"Bioinformatics"},{"key":"84053_CR56","unstructured":"Schr\u00f6dinger, LLC. The PyMOL Molecular Graphics System, Version 1.8 (2015)."},{"key":"84053_CR57","volume-title":"Amber 2019","author":"DA Case","year":"2019","unstructured":"Case, D. A. et al. Amber 2019 (University of California, San Francisco, 2019)."},{"key":"84053_CR58","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/jcc.10349","volume":"24","author":"Y Duan","year":"2003","unstructured":"Duan, Y. et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24, 1999\u20132012 (2003).","journal-title":"J. Comput. Chem."},{"key":"84053_CR59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput. Chem."},{"key":"84053_CR60","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N \u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"84053_CR61","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1080\/00268977700102571","volume":"34","author":"WF van Gunsteren","year":"1977","unstructured":"van Gunsteren, W. F. & Berendsen, H. J. C. Algorithms for macromolecular dynamics and constraint dynamics. Mol. Phys. 34, 1311\u20131327 (1977).","journal-title":"Mol. Phys."},{"key":"84053_CR62","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"84053_CR63","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jcc.24416","volume":"37","author":"TM Abramyan","year":"2016","unstructured":"Abramyan, T. M., Snyder, J. A., Thyparambil, A. A., Stuart, S. J. & Latour, R. A. Cluster analysis of molecular simulation trajectories for systems where both conformation and orientation of the sampled states are important. J. Comput. Chem. 37, 1973\u20131982 (2016).","journal-title":"J. Comput. Chem."},{"key":"84053_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0133172","volume":"10","author":"R De Paris","year":"2015","unstructured":"De Paris, R., Quevedo, C. V., Ruiz, D. D. A. & De Souza, O. N. An effective approach for clustering InhA molecular dynamics trajectory using substrate-binding cavity features. PLoS ONE 10, 1\u201325 (2015).","journal-title":"PLoS ONE"},{"key":"84053_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/prot.340170408","volume":"17","author":"A Amadei","year":"1993","unstructured":"Amadei, A., Limddrn, A. B. M. & Berendsen, H. J. C. Essential dynamics of peotenis Priteins. Proteins 17, 412\u2013425 (1993).","journal-title":"Proteins"},{"key":"84053_CR66","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1080\/07391102.2016.1231084","volume":"35","author":"Y Sixto-L\u00f3pez","year":"2017","unstructured":"Sixto-L\u00f3pez, Y. et al. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations. J. Biomol. Struct. Dyn. 35, 2794\u20132814 (2017).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"84053_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. V. M. D. Visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"84053_CR68","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"84053_CR69","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller","year":"2012","unstructured":"Miller, B. R. et al. MMPBSA.py: An efficient program for end-state free energy calculations. J. Chem. Theory Comput. 8, 3314\u20133321 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"84053_CR70","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jcc.10379","volume":"25","author":"H Gohlke","year":"2004","unstructured":"Gohlke, H. & Case, D. A. Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf. J. Comput. Chem. 25, 238\u2013250 (2004).","journal-title":"J. Comput. Chem."},{"key":"84053_CR71","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman, P. A. et al. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889\u2013897 (2000).","journal-title":"Acc. Chem. Res."},{"key":"84053_CR72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev, A., Bashford, D. & Case, D. A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins Struct. Funct. Bioinform. 55, 383\u2013394 (2004).","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"84053_CR73","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijbiomac.2017.12.162","volume":"111","author":"M Bello","year":"2018","unstructured":"Bello, M., Salda\u00f1a-Rivero, L., Correa-Basurto, J., Garc\u00eda, B. & S\u00e1nchez-Espinosa, V. A. Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR\/HER2. Int. J. Biol. Macromol. 111, 569\u2013586 (2018).","journal-title":"Int. J. Biol. Macromol."},{"key":"84053_CR74","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"84053_CR75","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1021\/acs.jctc.0c00063","volume":"16","author":"RA Boto","year":"2020","unstructured":"Boto, R. A. et al. NCIPLOT4: Fast, robust, and quantitative analysis of noncovalent interactions. J. Chem. Theory Comput. 16, 4150\u20134158 (2020).","journal-title":"J. Chem. Theory Comput."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84053-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84053-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84053-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:26:20Z","timestamp":1670041580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84053-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84053"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84053-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4659"}}